{"nct_id":"NCT03374254","title":"Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2018-02-16","start_date_type":"ACTUAL","primary_completion_date":"2021-09-08","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-18","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}